Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
By Erin Coe · June 22, 2011, 5:58 PM EDT
The Federal Circuit on Wednesday upheld the invalidity of Tyco Healthcare Group LP's patent covering temazepam formulations for its sleep aid Restoril, which it asserted in an infringement suit against Mutual...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login